Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals, Inc. (ANEB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ANEB · as of Jun 9, 2026
Key Statistics
Explore Anebulo Pharmaceuticals, Inc. Data
aneb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 75.0%
The ANEB analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing +1565.74% upside from the current price of $0.36.
Competitors & Peers
aneb competitorsANEB
CLNN
COYA
ESLA
IMMX
MGNXStock Performance
Full HistoryAbout Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals, Inc. is a biotechnology firm currently in the clinical trial phase, committed to devising and introducing treatments for individuals affected by severe cannabinoid poisoning a…
what is anebulo pharmaceuticals, inc. · aneb stock overview · anebulo pharmaceuticals, inc. company profile · who is anebulo pharmaceuticals, inc. ceo · aneb OTC · anebulo pharmaceuticals, inc. headquarters · anebulo pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Anebulo Pharmaceuticals, Inc. (ANEB) is a Healthcare company in the Biotechnology industry, listed on OTC since May 7, 2021. As of the latest trading session, ANEB stock price is $0.36, with a market capitalization of $14.7M. The stock has returned -67.25% over the past 12 months and -64.34% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Anebulo Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $6.00. In fiscal year 2025, Anebulo Pharmaceuticals, Inc. reported revenue of — and net income of -$8.5M. For detailed data — including Anebulo Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Anebulo Pharmaceuticals, Inc. (ANEB) stock price is $0.36. The stock is traded on OTC under the ticker symbol ANEB. The 52-week range is $0.30 – $3.42.